Identification of three mouse μ-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon

Gene

Volumn 388, Issue 1-2, 2007, Pages 135-147

  Doyle, Glenn A ^a   Rebecca Sheng, X ^a   Lin, Sharon S J ^a   Press, Danielle M ^a   Grice, Dorothy E ^a   Buono, Russell J ^a   Ferraro, Thomas N ^a   Berrettini, Wade H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C57BL 6; cDNA; DBA 2; Murine; Opiate receptor; Polymorphism

Indexed keywords

MESSENGER RNA; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR 1V; MU OPIATE RECEPTOR 1W; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DATA BASE; EXON; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPRM1 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THALAMUS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; DNA, COMPLEMENTARY; EXONS; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY;

MURINAE;

EID: 33845803139     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.10.017     Document Type: Article

References (59)

1. Abbadie C., and Pasternak G.W. Differential in vivo internalization of MOR-1 and MOR-1C by morphine. NeuroReport 12 14 (2001) 3069-3072
2. Abbadie C., Pan Y.-X., Drake C.T., and Pasternak G.W. Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience 100 1 (2000) 141-153
3. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 3 (1990) 403-410
4. Becerra L., Harter K., Gonzalez R.G., and Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naïve healthy volunteers. Anesth. Analg. 103 1 (2006) 208-216
5. Belknap J.K., Crabbe J.C., Riggan J., and O'Toole L.A. Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology 112 (1993) 352-358
6. Berrettini W.H., Ferraro T.N., Alexander R.C., Buchberg A.M., and Vogel W.H. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat. Genet. 7 (1994) 54-58
7. Blom N., Gammeltoft S., and Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294 5 (1999) 1351-1362
8. Bolan E.A., Pan Y.X., and Pasternak G.W. Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm1. Synapse 51 1 (2004) 11-18
9. Chowdhury B., et al. Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3′-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J. Biol. Chem. 280 19 (2005) 18959-18966 (Electronic publication 2005 Mar 2)
10. Claing A., Laporte S.A., Caron M.G., and Lefkowitz R.J. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog. Neurobiol. 66 2 (2002) 61-79
11. Evans C.J. Agonist selective mu-opioid receptor trafficking in rat central nervous system. Mol. Psychiatry 5 2 (2000) 121
12. Ferguson S.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 1 (2001) 1-24
13. Ferraro T.N., et al. Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains. Neuropsychopharmacology 30 (2005) 742-746
14. Giros B., Pohl M., Rochelle J.M., and Seldin M.F. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life. Sci. 56 18 (1995) PL369-PL375
15. Guang W., Wang H., Su T., Weinstein B., and Wang J.B. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol. Pharmacol. 66 (2004) 1285-1292
16. Han W., et al. Intracisternal A-particle element in the 3′ noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity. Pharmacogenet Genomics 16 6 (2006) 451-460
17. Horowitz G.P., Whitney G., Smith J.C., and Stephan F.K. Morphine ingestion: genetic control in mice. Psychopharmacology 29 (1977) 119-122
18. Huang H.D., Lee T.Y., Tzeng S.W., and Horng J.T. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res 33 (2005) W226-W229 (Jul 1, Web Server issue)
19. Hughes T.A. Regulation of gene expression by alternative untranslated regions. Trends Genet. 22 3 (2006) 119-122 (Electronic publication 2006 Jan 23)
20. Jones S., and Yakel J.L. Casein kinase ii (protein kinase ck2) regulates serotonin 5-HT(3) receptor channel function in NG108-15 cells. Neuroscience 119 3 (2003) 629-634
21. Kasai S., et al. Involvement of the 3′ non-coding region of the mu opioid receptor gene in morphine-induced analgesia. Psychiatry Clin. Neurosci. 60 Suppl 1 (2006) S11-S17
22. Kaufman D.L., et al. Characterization of the murine μ opioid receptor gene. J. Biol. Chem. 270 26 (1995) 15877-15883
23. Keith D.E., et al. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271 32 (1996) 19021-19024
24. Keith D.E., et al. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53 3 (1998) 377-384
25. Kent W.J. BLAT - the BLAST-like alignment tool. Genome Res. 12 4 (2002) 656-664
26. Ko J.L., Minnerath S.R., and Loh H.H. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophys. Res. Commun. 234 2 (1997) 351-357
27. Koch T., Schulz S., Schröder H., Wolf R., Raulf E., and Höllt V. Carboxy-terminal splicing of the rat μ opioid recptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 22 (1998) 13652-13657
28. Koch T., et al. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276 33 (2001) 31408-31414
29. Kozak C.A., Filie J., Adamson M.C., Chen Y., and Yu L. Murine chromosomal location of the μ and κ opioid receptor genes. Genomics 21 3 (1994) 659-661
30. Kreek M.J., and Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51 1-2 (1998) 23-47
31. Kvam T.-M., Baar C., Rakvag T.T., Kaasa S., Krokan H.E., and Skorpen F. Genetic analysis of the murine μ opioid receptor: increased complexity of Oprm1 gene splicing. J. Mol. Med. 82 4 (2004) 250-255
32. Liang Y., and Carr L.G. Transcription of the mouse mu-opioid receptor gene is regulated by two promoters. Brain Res. 769 2 (1997) 372-374
33. Liang Y., Mestek A., Yu L., and Carr L.G. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679 1 (1995) 82-88
34. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., and Wei L.N. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54 2 (1998) 321-326
35. Matthes H.W., et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 6603 (1996) 819-823
36. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. U. S. A. 91 19 (1994) 9081-9085
37. Onoprishvili I., Andria M.L., Kramer H.K., Ancevska-Taneva N., Hiller J.M., and Simon E.J. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol. Pharmacol. 64 (2003) 1092-1100
38. Pak Y., O'Dowd B.F., and George S.R. Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 272 40 (1997) 24961-24965
39. Pan Y.X. Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm1) that generates eight splice variants. Gene 295 1 (2002) 97-108
40. Pan Y.X. A diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 24 11 (2005) 736-750
41. Pan Y.X., et al. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol. Pharmacol. 56 2 (1999) 396-403
42. Pan Y.X., et al. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466 2-3 (2000) 337-340
43. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm1 gene. Proc. Natl. Acad. Sci. U. S. A. 98 24 (2001) 14084-14089
44. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel MOR-1B splice variants of the mouse mu opioid receptor gene: functional consequences of C-terminus splicing. Mol. Pharmacol. 68 3 (2005) 866-875
45. Pasternak G.W. The pharmacology of mu analgesics: from patients to genes. Neuroscientist 7 3 (2001) 220-231
46. Perroy J., Gutierrez G.J., Coulon V., Bockaert J., Pin J.P., and Fagni L. The C terminus of the metabotropic glutamate receptor subtypes 2 and 7 specifies the receptor signaling pathways. J. Biol. Chem. 276 49 (2001) 45800-45805
47. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59 3 (1995) 423-450
48. Schuller A.G.P., et al. Retention of herion and morphine-6β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2 2 (1999) 151-156
49. Simen A.A., Lee C.C., Simen B.B., Bindokas V.P., and Miller R.J. The C terminus of the Ca channel alpha1B subunit mediates selective inhibition by G-protein-coupled receptors. J. Neurosci. 21 19 (2001) 7587-7597
50. Smit, A.F.A., Hubley, R., Green, P. unpublished data. Current Version: open-3.1.
51. Sora I., et al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94 4 (1997) 1544-1549
52. Sternini C., et al. Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 93 17 (1996) 9241-9246
53. Tanowitz M., and von Zastrow M. A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J. Biol. Chem. 278 46 (2003) 45978-45986
54. Tian M., et al. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp. Med. 185 8 (1997) 1517-1522
55. Whistler J.L., et al. Modulation of postendocytic sorting of G protein-coupled receptors. Science 297 5581 (2002) 615-620
56. Wolf R., et al. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ opioid receptor. Mol. Pharmacol. 55 2 (1999) 263-268
57. Wood P.L., and Iyengar S. Central actions of opiates and opioid peptides; In vivo evidence for opioid receptor multiplicity. In: Pasternak G.W. (Ed). The Opiate Receptors (1988), Humana Press Inc., Clifton, N.J. 307-356
58. Zaki P.A., Keith Jr. D.E., Brine G.A., Carroll F.I., and Evans C.J. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?. J. Pharmacol. Exp. Ther. 292 3 (2000) 1127-1134
59. Zimprich A., Simon T., and Höllt V. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359 2-3 (1995) 142-146